Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
663
datasets available to search
ShareScore release 0.9.0
Dataset results
663 results for “Statins”
Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)
ClinicalTrials.gov study NCT02023879. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Genetically Guided Statin Therapy
ClinicalTrials.gov study NCT01894230. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
ClinicalTrials.gov study NCT02642159. IPD Sharing: Not stated. Countries: 15. Publications: 5.
Randomized Study of Obicetrapib as an Adjunct to Statin Therapy
ClinicalTrials.gov study NCT04753606. IPD Sharing: NO. Countries: 1. Publications: 1.
Niacin Plus Statin to Prevent Vascular Events
ClinicalTrials.gov study NCT00120289. IPD Sharing: Not stated. Countries: 2. Publications: 10.
Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
ClinicalTrials.gov study NCT00456365. IPD Sharing: NO. Countries: 1. Publications: 7.
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
ClinicalTrials.gov study NCT01988571. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Statin Therapy in Heart Failure: Potential Mechanisms of Benefit
ClinicalTrials.gov study NCT00233480. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin
ClinicalTrials.gov study NCT02584504. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Statin Therapy to Improve Atherosclerosis in HIV Patients
ClinicalTrials.gov study NCT00965185. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins
ClinicalTrials.gov study NCT01342211. IPD Sharing: Not stated. Countries: 2. Publications: 3.
The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation
ClinicalTrials.gov study NCT00579098. IPD Sharing: Not stated. Countries: 1. Publications: 5.
STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
ClinicalTrials.gov study NCT02943590. IPD Sharing: NO. Countries: 2. Publications: 4.
Data from: Statin use and cognitive function: population-based observational study with long-term follow-up
We aimed to evaluate the association between statin use and cognitive function. Cognitive function was measured with the Ruff Figural Fluency Test (RFFT; worst score, 0; best score, 175 points) and the Visual Association Test (VAT; low performance, 0–10; high performance, 11–12 points) in an observational study that included 4,095 community-dwelling participants aged 35–82 years. Data on statin use were obtained from a computerized pharmacy database. Analysis were done for the total cohort and subsamples matched on cardiovascular risk (N = 1232) or propensity score for statin use (N = 3609). We found that a total of 904 participants (10%) used a statin. Statin users were older than non-users: mean age (SD) 61 (10) vs. 52 (11) years (p<0.001). The median duration of statin use was 3.8 (interquartile range, 1.6–4.5) years. Unadjusted, statin users had worse cognitive performance than non-users. The mean RFFT score (SD) in statin users and non-users was 58 (23) and 72 (26) points, respectively (p<0.001). VAT performance was high in 261 (29%) statin users and 1351 (43%) non-users (p<0.001). However, multiple regression analysis did not show a significant association of RFFT score with statin use (B, −0.82; 95%CI, −2.77 to 1.14; p = 0.41) nor with statin solubility, statin dose or duration of statin use. Statin users with high doses or long-term use had similar cognitive performance as non-users. This was found in persons with low as well as high cardiovascular risk, and in younger as well as older subjects. Also, the mean RFFT score per quintile of propensity score for statin use was comparable for statin users and non-users. Similar results were found for the VAT score as outcome measure. In conclusion, statin use was not associated with cognitive function. This was independent of statin dose or duration of statin use.
Supplemental material for "Statins, type 2 diabetes and body mass index: a univariable and multivariable Mendelian randomization study"
<p>Supplemental material for "Statins, type 2 diabetes and body mass index: a univariable and multivariable Mendelian randomization study" by Guoyi Yang and C Mary Schooling.</p>
Dataset for Doshi et al. "The Possible Harms of Statins: What do Product Labels, Patient Package Inserts, and Pharmacy Leaflets Tell Us?"
<p>Dataset including all prescribing information (drug labels), patient package inserts, and pharmacy leaflets used in our study, as well as our extraction sheets.</p>
Dataset for "Assessing muscle-related adverse events in randomized trials of statins"
<p>Contains our extraction sheets with additional notes/comments on methods used in our study.</p>
LIFESTAT - Living With Statins, a Cross Sectional Study
ClinicalTrials.gov study NCT02250677. IPD Sharing: NO. Countries: 1. Publications: 14.
Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease
ClinicalTrials.gov study NCT00305201. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study
ClinicalTrials.gov study NCT06052020. IPD Sharing: YES. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.